chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rheumatoid Arthritis; stiffed and inflamed hands; stiffed and inflamed hands,swelling; inflamed hands; osteoarthritis; can not close her hand all the way in the morning; severe pain; pain in her both wrists; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.     On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) (seriousness criterion medically significant), MUSCULOSKELETAL STIFFNESS (stiffed and inflamed hands), PERIPHERAL SWELLING (stiffed and inflamed hands,swelling), PERIPHERAL SWELLING (inflamed hands), OSTEOARTHRITIS (osteoarthritis), MOBILITY DECREASED (can not close her hand all the way in the morning), PAIN (severe pain) and ARTHRALGIA (pain in her both wrists). The patient was treated with PREDNISONE at an unspecified dose and frequency; HYDROXYCHLOROQUINE at an unspecified dose and frequency; MELOXICAM at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid Arthritis), MUSCULOSKELETAL STIFFNESS (stiffed and inflamed hands), PERIPHERAL SWELLING (stiffed and inflamed hands,swelling), PERIPHERAL SWELLING (inflamed hands), OSTEOARTHRITIS (osteoarthritis), MOBILITY DECREASED (can not close her hand all the way in the morning), PAIN (severe pain) and ARTHRALGIA (pain in her both wrists) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-260274 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Case has been  upgraded to Serious for the IME event of Rheumatoid Arthritis.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pain; Nausea; Expired vaccine used; Itchiness; Diarrhea; Shortness of breath; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (Itchiness), DIARRHOEA (Diarrhea), DYSPNOEA (Shortness of breath), PAIN (Pain) and NAUSEA (Nausea) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diverticulitis since November 2011, Blood pressure high since 1989, Irritable bowel syndrome (The patient's diarrhea got worse but improved over time.), Sulfonamide allergy (sulfur allergy since childhood, mild nausea and diarrhea.) and Arthritis. Concomitant products included PARACETAMOL (TYLENOL ARTHRITIS PAIN) from 2000 to an unknown date for Arthritic pains.    On 26-Oct-2021 at 2:44 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Oct-2021, the patient experienced DYSPNOEA (Shortness of breath). On 26-Oct-2021 at 2:44 AM, the patient experienced PRURITUS (Itchiness) and DIARRHOEA (Diarrhea). 26-Oct-2021 at 2:44 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced PAIN (Pain) and NAUSEA (Nausea). On 26-Oct-2021, DYSPNOEA (Shortness of breath) had resolved. On 26-Oct-2021 at 2:44 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. On 28-Oct-2021, PRURITUS (Itchiness) and DIARRHOEA (Diarrhea) had resolved. At the time of the report, PAIN (Pain) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  The patient received unspecified medication for pain and nausea.   Most recent FOLLOW-UP information incorporated above includes: On 09-Nov-2021: Follow-up received added patient demographics. Added other relevant history of the patient. Added events (shortness of breath, nausea, and pain), and added outcome of events.
INJECTION SITE SWELLING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On APR-2021, the subject experienced injection site swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of injection site swelling was not reported. This report was non-serious.
After receiving his vaccine, patient took a nap. When he woke up at 4:00 PM he was shaking, his hands and feet were purple in color, and he had rapid breathing. While we were preparing to take him to the emergency room, he began vomiting repeatedly until he was dry heaving. He then became pale, lethargic, and we observed a redness on his limbs with a blotchy webbing pattern. We took him to the emergency room and explained he was having an allergic reaction to a vaccine he received. They tried to tell us it was normal. They never checked his vitals. They gave him anti-nausea medicine, Benadryl, and Tylenol. They discharged us after 1 hour and we continued to monitor him at home.
Arthritis first appeared as nodules on my hands. Then I noticed them on my forearms, and I got one on my foot. PCP suggested this might be rheumatoid arthritis and referred me to a Rheumatologist that I can't get into see until September. Every day I discover a new knot.
Patient received both the smp and anthrax vaccine on March 13, 2004. He reported no problems until 5am on 3/20 when he woke up from his sleep with chest pain. Pain described as tightness on left side described as " someone sitting on my chest and constant pressure." Did have occasional pain to his left shoulder and some throat tightness. Pain lasted 2 hrs and 45 minutes. With intensity rated from 4-9 with 10 being the worse. Stated the pain started to subside on his way to the emergency room and returned again at 11 am and at 7:15 pm. Each episode lasted 2-4 hrs. With each occurrence he denied shortness of breath, nausea, and diaphoresis. Has been pain free since episode at 7:15 on 3/20. Denies any fever. He reports that he has never had pain like this before. States that he is physically active.  3-23: Pt states he is feeling better and that his enzymes are returning to normal. Pt anticipates discharge.  PT ENROLLED IN MYOPERICARDITIS FOLLOWING SMP REGISTRY.   Nurse follow up on 05/27/04 states: "Per review of hospital record, the diagnosis is probable myopericarditis after smallpox vaccine. (Both myocarditis and pericarditis are already coded)"
TINY BLOOD SPOTS ON THE LEFT THIGH, LEFT SIDE OF FOREHEAD AND NEAR BOTH EYES; CHEST PAIN; SHORTNESS OF BREATH; PERSISTENT ABDOMINAL PAIN; BLURRED VISION; LEG PAIN; MUSCLE ACHE; FEVER; FATIGUE; HEADACHE; SORENESS IN RIGHT ARM; This spontaneous report received from a patient concerned an 18 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergies, and allergic to pineapples. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 15-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-JUN-2021, the subject experienced soreness in right arm. On 16-JUN-2021, the subject experienced tiny blood spots on the left thigh, left side of forehead and near both eyes. On 16-JUN-2021, the subject experienced chest pain. On 16-JUN-2021, the subject experienced shortness of breath. On 16-JUN-2021, the subject experienced persistent abdominal pain. On 16-JUN-2021, the subject experienced blurred vision. On 16-JUN-2021, the subject experienced leg pain. On 16-JUN-2021, the subject experienced muscle ache. On 16-JUN-2021, the subject experienced fever. On 16-JUN-2021, the subject experienced fatigue. On 16-JUN-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 99.8 to 100.2. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness in right arm, headache, fatigue, muscle ache, fever, chest pain, shortness of breath, blurred vision, persistent abdominal pain, leg pain, and tiny blood spots on the left thigh, left side of forehead and near both eyes. This report was non-serious.
Severe itching for 30 minutes and administered 2 Benadryl tablets that took effect after an hour. Very gassy and stomach ache.  Headache
No adverse events; Temperature excursion; This spontaneous report was received from a Medical Assistant, refers to a patient of unknown age and gender. Information regrading the patient's pertinent medical history, known allergies, concurrent conditions and concomitant therapies was not provided.      On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) lot # T008697 with expiration date on 04-JUN-2021 (strength, route and dose were not provided) for prophylaxis.         On 16-NOV-2020, it was found that hepatitis a vaccine, inactivated (VAQTA), experienced a temperature excursion of 3.0F, on a time frame of 3 hours and 30 minutes. Information regrading previous excursions was not provided. Call was made due to a data logger. The reported stated that the patient had no adverse reactions.   This is one of several reports received by the same source. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); devicelotnumber: T008697; expirationdate: 04-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2011USA010999: US-009507513-2012USA006031:
The person received the first Moderna vaccine by accident.  Per the CDC guidance, the second Moderna was provided as off-label use.
Very bad rash on left elbow, shoulder and between knees.  Very warm to touch on upper right arm, not just around the injection sight.
According to Mom, that evening patient started with mild temperature elevation (Up to 100.3) and was given Tylenol. The next morning he woke up with significant swelling and redness of the L upper arm. The swelling stretched from his L shoulder to his L elbow. He skin was also very warm to the touch  and tight in this area. When he was seen in our office on 11/20/19 for this reaction, he was started of Benadryl around the clock and encouraged to return to the office tomorrow for follow up.
After the booster I had angioedema (swelling of face hands and feet). I also developed urticaria. I also had a fever for 36 hours. I also had fatigue. I now have allergic reactions to eggs and sesame which I have never had it before.
Patient received a children's dose of the Pfizer Covid-19 vaccine instead of an adult dose.
Developed itching and ringing in both ears that has continued with periodic headaches. I have gone to an ENT specialist. 5/11/2021
Vomiting & elevated temp began 2 hrs p/vax recvd; temp does not respond to APAP & APAP not retained due to vomiting; site of vax is swollen but not red; pt is lethargic & crying/whining when awake; sx have persisted x 2 days; dx w/pneumonia
3 SMALL PUSTULES AT SITE OF INJECTION (TOTAL SIZE: DIME SIZED AREA); ITCHING AT INJECTION SITE WHERE PUSTULES LOCATED; MEMBER WENT TO PCP AND RECEIVED.
This spontaneous report was received from an approximately 69 year old female consumer reporting on herself. Medical history and drug reactions or allergies were not reported. In September 2013 the patient was vaccinated with ZOSTAVAX 19400 plaque forming units (PFU) lot number, dosage, and route were not reported. Concomitant therapies included BENICAR. The consumer informed that in March 2014 the patient developed shingles on her face and forehead. The treatment given included cetirizine, tramadol, valacyclovir and methylprednisolone. There were not laboratories performed. The patient sought medical attention by an office visit. The outcome of the patients was not recovered. Additional information has been requested.
Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021 and administered on 12-Nov-2021.; No adverse event; patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021 and administered on 12-Nov-2021.) and NO ADVERSE EVENT (No adverse event) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021 and administered on 12-Nov-2021.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021 and administered on 12-Nov-2021.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021 and administered on 12-Nov-2021.).    No concomitant medications were reported.  It was reported that patient received the Monovalent expired dose of vaccine, it was first booster dose of Moderna COVID-19 vaccine. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 12-Nov-2021. The vial did not undergo any temperature excursions.  No treatment details were reported.
Client self attested that he had not received the flu shot this season, so he was given a Flucelvax on 10/25/23.  Upon looking in system Client already received a Flucelvax flu shot this season on 8/15/23.  Client did not report a vaccine reaction.
Office wishing well pediatric called and notified us of reaction to right arm. Complained of rash all over and purple spots: Cortisone Cream and Benadryl, then Prednisolone
Information has been received from a licensed practical nurse concerning a 24 year old female with no drug reaction, allergies or pertinent medical history who on 30-MAY-2007 was vaccinated with her first dose of Gardasil, 0.5 mL, IM (Lot # 658222/0927U).  Concomitant therapy included LOESTRIN FE.  After her initial vaccination of Gardasil, the patient experienced redness and a feeling of swelling of the throat.  The patient denied any respiratory difficulty.  The symptoms resolved within three days without requiring treatment and on 02-JUN-2007 the patient fully recovered.  No laboratory studies were performed.  The patient sought medical attention by calling the office.  Patient Quality Complaints (PQC) was not involved.  On 30-JUL-2007 the patient received her second dose of Gardasil and did not report any adverse reactions.  Additional information has been requested.
Patient developed lower flank pain on the right side as well as a hard swollen area in the right deltoid.
not feeling well; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 28Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 2021, outcome "unknown", described as "not feeling well".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I do not have that information.  I have described the various adverse events above.  THe fevers last for 12-14 hours.  The shaking/chills lasted on and off for about 3 hours.  I felt ill for 2 days, then 2-3 days later I get the vasculitis attack, which lasts for a week and then subsides over the following week.  This has been consistent for the last two times I got the flu shot, although the worst event was in 2020.
Patient started feeling a bit ill at 9:15 PM so he went to bed.  At 2:30 AM he came into our room with a throbbing headache and laid on the floor (hard for him to move).  I took his temperature and he had 102.4 degree temperature and he was aching and said it was hard to move his head.  I put him in a tepid bath for 30 minutes and gave him Tylenol to reduce the fever.  Got him back in bed around 3:15 AM and now he was cold (put him in bed with blankets) and hour later (now 4:15 AM) burning hot and sweating, I got him out of bed (he had already kicked off all of the blankets and took his PJ's off)  he laid on our foyer marble floor (with a t shirt on and boxer shorts) for about 15 minutes and then went back to bed.  Woke up at 8:30 AM feeling fine and didn't have any more symptoms.  He did not go to school just stayed home but was fine.  My other 2 children (one 16 years old and the other 9 years old had no symptoms at all and were completely fine).
Patient received an HD-flu shot and a Spikevax Moderna booster. Patient reported being in cancer remission, with lymph nodes removed, and requested we administer both shots in her left arm, which was done. Patient later called back to say she had misremembered and should have told us to administer the shots in her right arm, and was asking what she should do. Counseled patient about decreased efficacy and possible swelling, and to follow up with her doctor on Monday.
Increased anxiety (has not gone away), increased memory loss, confusion, forgetfulness, harder to concentrate, harder to think and to put together sentences and thoughts.
Diarrhea, nausea and upset stomach starting 01/31/2021 night. Still ongoing (diarrhea stopped but nausea and stomach still upset).  Headache that worsens with movement still ongoing
Patient admitted to hospital with shortness of breath, cough, fever, chills, nausea, and fatigue after vaccination.
Reports injection site redness and swelling. Tender to the touch. Seen at urgent care 9/21/14 was treated with BACTRIM and MEDROL dose pak. 9/22/14 follow up for symptoms. (Symptoms improved today).
Post menopausal bleeding? I have not had a menstrual  cycle for 2 plus years
Patient states she received her booster of Moderna on 12/3. When patient woke up Saturday, 12/4, her right arm was numb and her fingers on her right hand were numb. As the week has progressed, her symptoms have lessened.
Atrial fibrilation, new onset, 4 hours in ER with IV and multiple meds to regulate . Follow up with Echo, 2 weeks heart monitor, see cardiologist, blood thinner medication
The day after her MMR and Hep. B shot (very first MMR) she was itchy and pulled handfuls of hair out of her head.  Two days later she was very irritable and again seemed to be itchy and pulling at her clothes around her neck, and had very chapped lips.  By the fourth day after the injections, her cheeks were inflamed, swollen, and covered in a rash.  Her eyes were swollen and she had a pink dotted rash all over, mainly around her neck and mouth, and a very bad rash all over the diaper area.  By the fifth morning we took her to the Dr's office.  Her skin looks like it has been severly burned around her neck and mouth.  Her eyes are still swollen and face extremely chapped looking.  She is very irritable and itchy.  We have given her motrin for pain and benedryl for itching but have not seen any relief.  I am very worried and need to know if there have been other reports of this and if there are any permanent damage from this and when it might clear up.  Please help.
patient falsely represented age 2 times during vaccination. once on line questionnaire and once verbally.
Systemic: Abdominal Pain-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe, Systemic: Nausea-Medium, Systemic: Shakiness-Severe, Systemic: Weakness-Severe, Additional Details: Pt complained of abdominal soreness, then proceeded to faint about 2 min after administration. She responded immediately while she was laying on her back. Needed assistance to transition to a seated position. At this point, she fainted again. EMS was called. Before they arrived, she was attentive and could walk on her own. BP was 110/60, pt refused transport to the hospital. After another 15 min observation, pt walked out on her own. Family member drove her home out of an abundance of caution.